Redesigning Human Spaceflight: The Emerging Field of Bioastronautics

1. Introduction: The Emergence of Bioastronautics

The trajectory of human history is marked by a relentless expansion into new frontiers, yet the vacuum of space presents a barrier unlike any terrestrial ocean or mountain range. As humanity stands on the precipice of a new era in space exploration—transitioning from the relative safety of Low Earth Orbit (LEO) to deep space transit and planetary surface operations—the discipline of bioastronautics has emerged as the critical linchpin of mission success. Bioastronautics, defined as the study of the biological, behavioral, and medical effects of spaceflight on humans and other living organisms, sits at the turbulent intersection of biology, medicine, engineering, and space research.¹ It is a field that encompasses everything from the molecular dynamics of gene expression in microgravity to the macroscopic engineering of life-support systems and the architectural design of space habitats.³

For the past several decades, human experience in space has been largely confined to short-duration Shuttle missions or extended stays aboard the International Space Station (ISS), where the protective magnetosphere shields crews from the worst of galactic radiation and Earth is never more than a few hours away by emergency descent. However, the current strategic pivot toward the Moon via the Artemis program, and subsequently to Mars, fundamentally alters the risk profile. We are entering an era where the "Trinity" of mission constraints—logistics costs, technology limits, and human health risks—are dictating a complete redesign of how we approach space travel.⁵

The environment of deep space presents a unique and hostile confluence of stressors that the human body was never evolved to withstand. These include microgravity (or partial gravity on celestial bodies), ionizing radiation from Galactic Cosmic Rays (GCRs) and Solar Particle Events (SPEs), isolation, confinement, and the psychological immensity of the distance from Earth.¹ Recent research conducted in 2024 and 2025 has highlighted that these stressors do not act in isolation; rather, they create synergistic effects that accelerate physiological degradation. For instance, the fluid shifts that occur in weightlessness may exacerbate the risks associated with radiation-induced vascular damage, while the psychological stress of isolation can compromise immune function, leaving the crew vulnerable to opportunistic infections.⁶

This report provides an exhaustive analysis of the current state of bioastronautics, synthesizing recent advances in physiological countermeasures, radiation protection, environmental control, and human factors psychology. It explores the mechanisms of Spaceflight Associated Neuro-ocular Syndrome (SANS), the latest in pharmacological and mechanical interventions for musculoskeletal atrophy, and the revolutionary integration of synthetic biology into life support systems. Furthermore, it examines how these biological constraints and technological breakthroughs are reshaping mission architectures for the Artemis lunar program and future Mars expeditions. By integrating data from recent years regarding commercial space stations, artificial gravity initiatives, and analog simulations, this review elucidates the complex interplay between human biological fragility and the hostile vacuum of space, offering a comprehensive roadmap for the next generation of bio-regenerative exploration.

1.1 The Definition and Scope of Bioastronautics

Bioastronautics is not merely a sub-discipline of medicine; it is an integrative science that challenges the state of the art in human protection and integrative physiology. It spans the study and support of life in space, covering the design of space vehicle payloads, space habitats, and life-support systems.² The scope extends beyond the mission itself, encompassing pre-flight selection and preparation, in-flight health maintenance and performance optimization, and post-flight rehabilitation.⁸ It involves a collaborative set of relations spanning research, technology development, and operational policy, often requiring a seamless interface between academic research and operational deployment.³

The field is often categorized alongside "astronautical hygiene," which focuses on the identification and mitigation of specific hazards (like moon dust or chemical leaks), whereas bioastronautics takes a broader physiological and medical view of the organism's adaptation to the environment.² It is also distinct from, though related to, astrobiology, which concerns the origin and distribution of life in the universe. Bioastronautics focuses specifically on the effects of spaceflight on biological systems, including human physiology and psychology, and the engineering required to sustain them.⁴

1.2 The Shift from Visiting to Inhabiting

The upcoming missions to the Moon and Mars represent a paradigm shift from "visiting" space to "inhabiting" it. This distinction drives the need for technologies that are not just robust, but regenerative and autonomous. Current US approaches, which have historically relied on the resupply of food, water, and consumables, are logistically unsustainable for deep space exploration. The sheer mass required to support a crew for a three-year Mars mission using current ISS-style logistics would be prohibitive. Thus, bioastronautics is driving the development of bioregenerative life support systems—technologies that mimic Earth's biosphere to recycle waste into resources.⁵

Furthermore, the commercialization of space is expanding the demographic of space travelers. No longer limited to hyper-fit government astronauts, the bioastronautics community must now consider the health parameters of a broader population, including older individuals or those with pre-existing conditions, as commercial space stations like Vast’s Haven-1 prepare for launch.⁹ This democratization of spaceflight necessitates a broader understanding of human physiological variance and more personalized medical countermeasures.

2. The Neuro-Ocular Paradigm Shift: Deciphering SANS

One of the most perplexing and high-priority risks identified in long-duration spaceflight is Spaceflight Associated Neuro-ocular Syndrome (SANS). Formerly known as Visual Impairment Intracranial Pressure (VIIP) syndrome, SANS represents a unique constellation of ocular structural changes and visual anomalies that affect approximately 70% of crew members on long-duration missions.¹⁰ It serves as a prime example of how the space environment can fundamentally alter human physiology in unexpected ways.

2.1 Clinical Manifestation and Prevalence

SANS is characterized by a specific set of symptoms that can manifest as early as three weeks into a mission. These include optic disc edema (swelling of the optic nerve head), globe flattening (a physical shortening of the eye's axial length), choroidal folds (wrinkles in the vascular layer of the eye), and hyperopic (farsighted) refractive shifts.¹⁰ Astronauts have reported decreased near vision, necessitating the use of "space anticipation glasses" to correct for these shifts during missions.¹²

The prevalence of these symptoms is staggering. With nearly three-quarters of long-duration crew members affected, SANS is not an anomaly; it is a typical adaptation to the spaceflight environment.¹⁰ In a Mars mission scenario, where crew members must perform delicate operations—such as piloting a lander, repairing microscopic circuitry, or conducting robotic surgery—uncorrected visual impairment could be catastrophic. Unlike on the ISS, where glasses can be shipped on the next cargo resupply, a Mars crew must carry all necessary optical corrections or the means to manufacture them.¹²

2.2 Pathophysiological Mechanisms: The Glymphatic Hypothesis

Understanding the mechanism of SANS is arguably the "holy grail" of current bioastronautics ophthalmology. Initially, the dominant theory focused solely on the cephalad (headward) fluid shift caused by microgravity. On Earth, gravity pulls fluids toward the feet; in space, these fluids redistribute to the head, causing the characteristic "puffy face, bird legs" appearance. It was hypothesized that this fluid shift increased intracranial pressure (ICP), which directly compressed the optic nerve from behind.¹⁰

However, direct measurements and modeling have shown that the ICP elevation in space, while present, may not be sufficient to explain the severity of the ocular remodeling observed. This has led researchers in 2024 and 2025 to propose a more nuanced culprit: the glymphatic system. The glymphatic system is a macroscopic waste clearance pathway in the brain, dependent on cerebrospinal fluid (CSF) flow to remove metabolic waste products like amyloid-beta. It functions primarily during sleep and is regulated by the pressure gradients between the arterial and venous systems.¹³

The "Glymphatic Hypothesis" suggests that SANS may occur secondary to a failure or obstruction of this glymphatic outflow. In microgravity, the lack of gravitational drainage leads to venous congestion in the head and neck. This congestion increases the back-pressure in the dural venous sinuses, which impairs the drainage of CSF and interstitial fluid. The result is a localized accumulation of fluid around the optic nerve sheath, creating a "stagnant flow" environment that exerts mechanical stress on the back of the eye.¹⁴

This hypothesis aligns with evidence that SANS shares similarities with terrestrial conditions like Normal Pressure Hydrocephalus and venous outflow obstructions, yet it remains distinct. It also provides a critical link to another major factor: sleep. The glymphatic system is most active during deep sleep. Astronauts often suffer from poor sleep quality due to noise, circadian misalignment, and stress. If sleep is disrupted, the brain's ability to clear fluid and waste is compromised, potentially accelerating SANS progression.¹⁵ Thus, SANS is likely a multifactorial condition involving fluid physics, venous congestion, and sleep physiology.

2.3 Genetic Susceptibility and "Omics"

Not all astronauts develop SANS, which points to a genetic component. Recent research into the "one-carbon metabolism" pathway—a biochemical network involved in DNA synthesis and methylation—has identified specific genetic polymorphisms that may predispose individuals to SANS. Variations in genes related to homocysteine metabolism and B-vitamin processing appear to be correlated with a higher risk of developing ocular issues.¹²

This finding is part of a broader trend in "space-omics," where researchers are using genomic, proteomic, and metabolomic data to identify biomarkers of susceptibility. The goal is to develop a "risk profile" for each astronaut before launch. Those with high genetic susceptibility to SANS might be prioritized for preventative countermeasures or assigned to shorter duration missions.¹⁶

2.4 Emerging Countermeasures

The response to SANS has driven significant innovation in biomedical engineering and countermeasures. The 2025 review of SANS countermeasures highlights several strategies currently under evaluation, categorized into mechanical, gravitational, and pharmaceutical interventions.¹²

2.4.1 Mechanical Interventions

• Lower Body Negative Pressure (LBNP): This technique involves enclosing the lower half of the astronaut's body in a chamber that applies vacuum pressure (negative pressure). This suction draws fluids back down toward the legs, effectively simulating the hydrostatic pressure gradient of Earth gravity. While traditional LBNP devices were bulky metal cylinders (like the Russian Chibis suit), modern iterations are becoming more wearable and mobile. Research in 2025 has focused on "self-generated" LBNP devices that combine the vacuum seal with exercise equipment, allowing the astronaut to generate the negative pressure through physical activity, thereby saving power and mass.¹⁷ The goal is to use LBNP for specific durations daily to "reset" the fluid distribution.

• Venoconstrictive Thigh Cuffs (VTCs): Also known as Braslet cuffs, these are simple mechanical bands worn on the upper thighs. By tightening the cuffs, venous return from the legs is restricted, trapping blood in the lower extremities and reducing the volume of fluid shifting to the head. While effective for short-term symptom relief, they are less physiological than LBNP and can cause discomfort if worn for long periods.¹²

• Translaminar Pressure Gradient (TLPG) Modulation: This novel approach involves the use of specialized pressurized goggles (swimming goggle-style) that can increase the air pressure in front of the eye. Theoretically, by increasing the pressure on the front of the eye, one can balance the increased intracranial pressure pushing from behind the eye. This attempts to neutralize the pressure gradient that causes globe flattening and optic disc edema.¹⁰

2.4.2 Pharmaceutical and Nutritional Approaches

• Precision Nutrition: Based on the genetic findings regarding one-carbon metabolism, precision nutritional supplementation is being investigated. This involves supplementing astronauts with specific B-vitamins (folate, B12, B6) to optimize the metabolic pathway and potentially reduce the biochemical susceptibility to SANS.¹²

• Pharmacological Agents: While specific drugs are still in trial phases, targets include agents that reduce CSF production (like acetazolamide, though side effects are a concern) or enhance venous tone. Metformin, primarily a diabetes drug, is also being looked at for its pleiotropic effects on inflammation and potential fluid regulation, although its primary space interest remains radioprotection.¹⁹

The complexity of SANS illustrates a broader theme in modern bioastronautics: space physiology is a system-of-systems problem. The eye is not failing in isolation; it is failing because the cardiovascular, lymphatic, and cerebrospinal systems are adapting to a new physics environment.

3. Musculoskeletal Adaptation and Countermeasures

The degradation of bone and muscle in microgravity is perhaps the most well-characterized risk of spaceflight, yet it remains a persistent challenge for multi-year missions. Without the constant loading of gravity, the human body efficiently dismantles "unnecessary" structural tissue, a process that mimics accelerated aging.

3.1 The Physiology of Unloading

In the absence of gravitational loading, the body suppresses anabolic (growth) signaling pathways and enhances catabolic (breakdown) pathways. This results in rapid muscle atrophy, particularly in the "anti-gravity" muscles (calves, quadriceps, back extensors), and progressive bone loss, leading to a condition similar to osteoporosis but progressing at a much faster rate.¹⁶

Recent molecular studies, including space-omics and cross-species comparisons using rodents and Caenorhabditis elegans (nematodes), have revealed that these responses are evolutionarily conserved. Unloading triggers mitochondrial stress and systemic inflammation. This process is mediated by signaling molecules known as myokines (released from muscle) and osteokines (released from bone). The discovery of this "crosstalk" implies that muscle atrophy contributes to bone loss and vice versa, creating a degenerative feedback loop.¹⁶ For example, the protein myostatin, which inhibits muscle growth, is upregulated in space, while bone formation markers like IGF-1 are suppressed.

3.2 The Tendon Gap: A Hidden Risk

A critical and historically overlooked area is the adaptation of tendons and ligaments. Current research indicates that tendons, like bone and muscle, lose stiffness and structural integrity during unloading. This adaptation is insidious because it does not necessarily cause pain or immediate dysfunction in microgravity. However, it becomes particularly dangerous during "reloading" phases—such as landing on Mars or returning to Earth. A tendon that has become compliant (stretchy) in space may rupture when suddenly subjected to the high forces of walking in a gravity field.²¹

The lack of tendon-specific countermeasures is a major gap identified in 2024-2025 literature. Current exercise protocols on the ISS focus on high-load resistance training for muscle and bone but may not provide the specific strain rates or frequencies needed to maintain tendon matrix homeostasis.²¹

3.3 Next-Generation Countermeasures

The current gold standard for musculoskeletal protection is the Advanced Resistive Exercise Device (ARED) on the ISS, which allows astronauts to perform squats, deadlifts, and presses with loads up to 600 pounds using vacuum cylinders. While ARED is effective at mitigating significant muscle loss, it does not fully prevent bone resorption or the degradation of bone microarchitecture.²² Furthermore, the ARED is too large and heavy for a Mars transit vehicle, necessitating smaller, more efficient solutions.

3.3.1 Pharmaceutical Advancements

• Myostatin Inhibitors: New therapies targeting the myostatin/activin-A pathway are showing promise. Inhibiting myostatin removes the "brake" on muscle growth. Animal models and early human trials suggest that these inhibitors can induce muscle hypertrophy and protect bone density even in the absence of heavy exercise. This could be a game-changer for missions where exercise equipment must be smaller and lighter.²⁰

• Anabolic Agents: Agents like IGF-1 (Insulin-like Growth Factor 1) or BMP (Bone Morphogenetic Protein), delivered locally or systemically, are being explored to stimulate collagen synthesis in tendons and bone formation.²¹

• Bisphosphonates: Already used on the ISS, these drugs stop bone resorption (breakdown) but do not build new bone. Future protocols may combine bisphosphonates with anabolic agents (like parathyroid hormone analogs) to decouple the bone remodeling process, allowing for net bone gain even in space.²²

3.3.2 Personalized Medicine and Monitoring

The future of musculoskeletal maintenance lies in personalization. By leveraging bio-sensors and real-time monitoring of biomarkers (e.g., collagen fragments in urine or blood), flight surgeons could tailor exercise prescriptions daily. If an astronaut's biomarkers suggest high bone turnover, their resistance load could be increased, or a pharmacological agent administered immediately, rather than waiting for post-flight scans.¹⁶

4. The Radiation Barrier: Biological and Physical Defenses

If microgravity is the chronic debilitator, space radiation is the acute assassin and the long-term carcinogen. Deep space exposes crews to two primary types of radiation: Solar Particle Events (SPEs) and Galactic Cosmic Rays (GCRs). SPEs are bursts of protons from solar flares, which are intense but can be shielded against. GCRs, however, are high-energy heavy ions (atomic nuclei stripped of electrons) traveling at near-light speed, originating from supernovae and other galactic events. These are difficult to shield and highly damaging.⁷

4.1 The Threat Landscape

NASA's current estimates for a Mars mission (approximately 1,000 days round trip) predict radiation exposures ranging from 525 mSv (during solar maximum, when the sun's magnetic field deflects some GCRs) to 1,650 mSv (during solar minimum). To put this in perspective, the traditional NASA career limit for astronauts has been around 600 mSv (variable by age and sex), meaning a single Mars mission could exceed an astronaut's lifetime allowance by nearly triple.⁷

Beyond cancer, recent findings emphasize the risk to the Central Nervous System (CNS). High-energy ions can traverse the hull and the human skull, leaving "track structures" of damage through brain tissue. These tracks are dense columns of ionization that kill cells or alter neuronal function. This can result in cognitive impairment, memory deficits, and accelerated neurodegeneration (e.g., Alzheimer's-like pathology).¹⁰

4.2 Physical Shielding Innovations

Traditional shielding involves mass—thick walls of aluminum or lead. However, heavy ions in GCRs interact with metal to produce "secondary radiation" (showers of neutrons and other particles) that can be more damaging than the original particle. Therefore, shielding strategy has shifted toward low-atomic-number (low-Z) materials like hydrogen, which scatter particles without producing as much secondary spray.

• Metal Matrix Composites: CSIRO has recently developed novel composite materials combining metals, intermetallics, and ceramics. These materials are lighter than aluminum, offer 40-50% better radiation attenuation, and maintain high structural stiffness. These shields were tested on the Binar-2 and Binar-3 satellites in late 2024, proving their efficacy in orbit. This technology allows for the protection of sensitive electronics and potentially crew habitats without the massive weight penalty of lead or thick aluminum.²⁶

• Regolith and In-Situ Resources: For surface habitats on the Moon or Mars, the plan is to use "in-situ resource utilization" (ISRU). Habitats will likely be buried under meters of lunar or Martian soil (regolith) or placed inside lava tubes. This bulk shielding is the only practical way to block GCRs effectively for long durations.²⁷

• Wearable Shielding: The AstroRad vest is a piece of personal protective equipment (PPE) designed to protect vital organs (specifically stem-cell-rich tissues like bone marrow) from SPEs. It allows astronauts to move around the cabin during a solar storm event rather than being confined to a small "storm shelter" for days. The vest uses varying thicknesses of polyethylene to optimize protection vs. weight.²⁷

4.3 Biological Radioprotection: The Final Line of Defense

Physical shielding can never fully block GCRs. This realization has birthed the field of biological radioprotection—enhancing the human body's intrinsic ability to repair DNA damage.

• Tardigrade Adaptation: Tardigrades (water bears) are microscopic animals capable of surviving extreme radiation. Researchers are investigating the "Dsup" (Damage suppressor) protein found in tardigrades. When human cells are engineered to express Dsup, they show significantly reduced DNA fragmentation under X-ray exposure. Current pathways involve creating drugs or gene therapies that could transiently upregulate these protective proteins in astronauts during high-risk mission phases.²⁸

• Pharmaceutical Radioprotectors: Metformin, a common diabetes drug, has shown surprising radioprotective properties in human fibroblasts and mice, reducing oxidative stress and DNA damage.¹⁹ Other candidates include antioxidants and specific gene therapies that enhance the Non-Homologous End Joining (NHEJ) DNA repair pathway.

• Synthetic Microbiota: Another frontier is engineering the gut microbiome. By introducing radio-resistant probiotic bacteria into the astronaut's gut, scientists hope to protect the intestinal lining from acute radiation syndrome and reduce systemic inflammation. These "synthetic microbiota" could serve as a living shield for the gastrointestinal tract.²⁹

5. Closing the Loop: Advanced Life Support and Synthetic Biology

For a mission to Mars, resupply is impossible. Every drop of water, molecule of oxygen, and calorie of food must be recycled or produced on board. This requirement is driving the evolution of Environmental Control and Life Support Systems (ECLSS) from physicochemical machinery to bio-regenerative ecosystems.

5.1 Water Recovery: The 98% Milestone

On the ISS, water recovery has recently achieved a critical milestone: 98% recovery. This was accomplished by integrating the Water Processor Assembly (WPA) with a new Brine Processor Assembly (BPA). In the previous system, the "brine" (concentrated urine and flush water left over from distillation) was discarded. The BPA now extracts the remaining water from this brine, leaving behind a solid salt puck. This 98% efficiency is considered the threshold required for a viable Mars transit.³⁰

However, the ISS system relies on heavy, consumable filters and hazardous chemicals (like strong acids used for urine pretreatment to prevent clogging). Future systems must be "consumable-free." Technologies like biomimetic membranes (using aquaporin proteins) or catalytic oxidation are being developed to purify water without needing replacement filters from Earth. The goal is a system that can run for three years with zero consumables.³²

5.2 Synthetic Biology and Space Food

The "salad machine" concept (growing lettuce in the Veggie unit) is psychologically beneficial but nutritionally insufficient for a crew's caloric needs. Recent advances in synthetic biology are attempting to decouple food production from photosynthesis, which is energy-inefficient and requires massive volume.

• Food from Air: The European Space Agency (ESA) is testing "Solein," a protein powder produced by microbes. These microbes are fed hydrogen (from water electrolysis), carbon dioxide (from cabin air), and minerals, using electricity as the energy source. This process uses no arable land and minimal water. In 2024-2025, experiments like the HOBI-WAN project are refining this for space, potentially using urea (from astronaut urine) as the nitrogen source. This could allow a spacecraft to produce high-quality protein continuously using only waste products and power.³⁴

• Bio-Manufacturing: The BioNutrients experiments on ISS are testing yeast strains (Saccharomyces cerevisiae) engineered to produce specific micronutrients (like beta-carotene or zeaxanthin) on demand. Instead of carrying vitamin pills that degrade over 3 years, astronauts would carry dehydrated yeast spores. When nutrients are needed, they would wake up the spores, feed them sugar, and consume the nutrient-rich culture. This "just-in-time" manufacturing is crucial for maintaining crew health over long durations.³⁵

• Lunar Agriculture (LEAF): The Lunar Effects on Agricultural Flora (LEAF) experiment, slated for Artemis III, will be the first to grow plants on the lunar surface. It will test how crops handle the combined stressors of partial gravity and deep-space radiation, serving as a pathfinder for lunar greenhouses. This experiment will provide critical data on whether plants can germinate and photosynthesize effectively in the harsh lunar environment.³⁶

6. The Psychological Frontier: Resilience in Isolation

The psychological pressures of interplanetary travel are distinct from LEO missions. On Mars, the communication delay (up to 22 minutes one way) means real-time conversation with family or mission control is impossible. The crew is effectively alone, a phenomenon known as the "break-off effect" but amplified to a planetary scale.

6.1 Lessons from CHAPEA

The Crew Health and Performance Exploration Analog (CHAPEA) missions at NASA Johnson Space Center are simulating this reality. Four crew members live in a 1,700-square-foot 3D-printed habitat ("Mars Dune Alpha") for over a year, experiencing realistic delays, resource constraints, and isolation.

Initial results from CHAPEA Mission 1 (concluded mid-2024) have highlighted unexpected coping mechanisms. While standard psychological support (private conferences, care packages) is unavailable, crews have utilized immersive VR environments and even cooperative video gaming to maintain team cohesion and cognitive sharpness.³⁸ The shared activity of gaming provided a release valve for stress and a way to bond that did not involve work tasks. This suggests that future mission planning should include sophisticated entertainment systems as "psychological countermeasures".³⁹

6.2 Cognitive Resilience and Automated Therapy

To address the lack of real-time psychiatric support, researchers are developing "automated psychotherapy" systems. These are AI-driven interfaces that allow astronauts to perform cognitive behavioral therapy (CBT) exercises or mindfulness training autonomously. The goal is to provide a confidential, always-available outlet for stress management when "Houston" is 20 minutes away.⁶

Furthermore, "space psychology" is moving towards a model of "eustress" (positive stress). Rather than trying to eliminate all stress, mission designers are looking to engineer challenges that foster growth and resilience—the "window of tolerance." This includes meaningful work, creative autonomy, and the ability to modify the habitat environment. The ability to customize their living space or grow plants gives astronauts a sense of agency that combats the helplessness of confinement.⁴¹

7. Gravity as a Variable: Artificial Gravity and Habitats

For decades, artificial gravity (AG) was deemed too complex and expensive for government space programs. However, the commercial space sector, driven by the goal of space tourism and habitation, has revived this concept.

7.1 Commercial Stations: Vast Haven-1

Vast Space has announced plans to launch Haven-1, the world's first commercial space station capable of generating artificial gravity. Scheduled for launch around late 2025 or 2026, Haven-1 is designed to rotate to produce lunar-equivalent gravity. This will be a crucial testbed for validating whether partial gravity (0.16g) is sufficient to prevent SANS and musculoskeletal loss, or if Earth-normal gravity (1g) is required.⁹

The station specs include a habitable volume of 45 cubic meters and the ability to host four crew members for up to 30 days. The rotation capability allows for the generation of centrifugal force, creating a "down" direction. This shift from government-led to commercial-led AG research is pivotal. If commercial stations can prove that AG prevents the debilitating effects of microgravity, it may force a redesign of the Mars transport architecture. Instead of a static tube, the Mars transit vehicle might become a rotating tether system or a centrifuge-equipped ship.⁹

7.2 Centrifugation as a Countermeasure

Short of rotating the whole ship, short-radius centrifuges (SRC) are being investigated as an exercise device. An astronaut would spend 30-60 minutes a day spinning in a small centrifuge to push blood toward the feet and load the bones. While promising, engineering a vibrating, high-speed centrifuge inside a precise spacecraft remains a significant vibration isolation challenge. Studies suggest that intermittent centrifugation can maintain orthostatic tolerance and cardiovascular conditioning, but its effects on SANS and bone density are still being evaluated in ground-based bed rest studies.¹²

8. Integrated Mission Architectures: Artemis to Mars

The advances in bioastronautics are directly shaping the "Moon to Mars" architecture. Artemis is not just a return to the Moon; it is the proving ground for the biological technologies needed for Mars.

8.1 Artemis III and Beyond

Artemis III (targeted for 2026/2027) will deploy the first human surface science instruments, including the LEMS seismometer and the LEAF agricultural payload.⁴⁵ But more importantly, it will test the "Medical Kit" for deep space. The medical system for Artemis must handle trauma, dental emergencies, and radiation sickness without immediate evacuation capability. This has led to the development of "point-of-care" diagnostic devices—handheld ultrasounds, lab-on-a-chip blood analyzers—that allow the crew to diagnose and treat themselves.⁴⁶

The Artemis surface operations will also test the new exploration spacesuits (xEMU/AxEMU), which are designed with greater mobility to reduce the metabolic cost of moonwalks. These suits will incorporate biomedical sensors to monitor heart rate, CO2 levels, and metabolic rate in real-time, feeding data back to the wearer's display to prevent overexertion.⁴⁷

8.2 The Mars Design Reference Mission

The current Mars architecture is heavily influenced by the radiation and SANS limits.

• Speed is Safety: Because radiation accumulation and SANS risk are time-dependent, bioastronautics dictates that propulsion must be faster. Nuclear thermal propulsion is being pursued partly to reduce transit time to under 1,000 days, specifically to reduce biological exposure.

• Autonomy: The communication blackout dictates that the ECLSS and medical systems must be automated. The crew will rely on AI decision support systems for medical diagnostics.

• Pre-emplacement: Because humans cannot manufacture massive radiation shields, robotic missions may pre-deploy habitats covered in regolith before the crew arrives, minimizing their surface radiation dose.²⁷

8.3 The Medical Kit of the Future

The medical capability for a Mars mission must be a miniature hospital. It will include capabilities for simple surgery, dental repair, and psychiatric support. "Just-in-time" training modules will allow crew members to refresh their memory on medical procedures immediately before performing them. The integration of 3D printing for medical tools and sterile compounds is also a key area of development.⁴⁸

9. Conclusion

The field of bioastronautics has transitioned from a passive study of "what happens to the body" to an active engineering discipline of "how to force the body to survive." The advances of 2024 and 2025—from the identification of the glymphatic system's role in SANS to the testing of metal matrix shields and synthetic food reactors—demonstrate a maturation of the field.

We are learning that the human body is plastically adaptive but brittle in specific ways. The solutions are increasingly hybrid: biological problems (like radiation damage) are being met with biological solutions (gene therapy, tardigrade proteins), while physical problems (fluid shifts) are meeting mechanical solutions (LBNP, artificial gravity).

As we look toward Artemis III and the eventual Mars transit, our view of human spaceflight has shifted. It is no longer a camping trip with a return ticket; it is a migration. The success of this migration depends not just on the thrust of our rockets, but on the resilience of our cells, the stability of our minds, and the ingenuity of the life support systems that will carry a bubble of Earth across the cosmic void. The "biological showstoppers" are being systematically dismantled, turning the impossible voyage into a manageable risk.

Table 1: Comparison of Key Bioastronautics Countermeasures (Current vs. Future)

Risk Category	Current Standard (ISS/LEO)	Emerging/Future Countermeasure (Deep Space/Mars)
SANS (Vision)	Glasses, occasional photography	LBNP suits, Venous Cuffs, Glymphatic modulation, Artificial Gravity 12
Bone/Muscle	ARED (Resistive Exercise), Bisphosphonates	Myostatin inhibitors, Anabolic agents, Tuned vibration plates, Centrifugation 16
Radiation	Aluminum hull, Storm shelter, Dosimetry	Metal Matrix Composites, Regolith, Tardigrade gene therapy, Radioprotective drugs (Metformin) 26
Life Support (Water)	90-98% Recovery (Filters/Chemicals)	>98% Recovery (Biomimetic membranes), Brine processing, Closed-loop reliability 30
Food	Pre-packaged meals, limited fresh salad	Synthetic biology (Solein), Bio-nutrient yeast, Surface agriculture (LEAF) 34
Psychology	Weekly video calls, care packages	VR/Immersive environments, Automated AI therapy, Shared gaming 6
Gravity	None (Microgravity)	Rotating commercial stations (Haven-1), Short-radius centrifuges 9

Table 2: Estimated Radiation Exposures for Exploration Missions

Mission Profile	Duration	Estimated Dose Equivalent	Risk Context
ISS Mission	6 months	50–100 mSv	Well within career limits; LEO protected by magnetosphere.
Mars Transit (Solar Min)	~1000 days	~1650 mSv	Exceeds NASA career limits; high cancer/CNS risk.7
Mars Transit (Solar Max)	~870 days	~525 mSv	Lower GCR flux due to solar wind, but higher acute SPE risk.
NASA Career Limit	Lifetime	~600 mSv	(Varies by age/sex) Benchmark for acceptable risk (3% REID).

(Note: Solar Minimum allows more Galactic Cosmic Rays to enter the solar system, increasing background dose. Solar Maximum blocks GCRs but increases solar flare risk.)

Works cited

1. Bioastronautics Training Program - Harvard-MIT Health Sciences and Technology, accessed January 14, 2026, https://hst.mit.edu/academic-programs/memp/bioastronautics-training-program

2. Bioastronautics - Wikipedia, accessed January 14, 2026, https://en.wikipedia.org/wiki/Bioastronautics

3. Bioastronautics Roadmap - NASA Technical Reports Server, accessed January 14, 2026, https://ntrs.nasa.gov/api/citations/20050081847/downloads/20050081847.pdf

4. Domains of life sciences in spacefaring: what, where, and how to get involved - PMC, accessed January 14, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10825151/

5. Critical investments in bioregenerative life support systems for bioastronautics and sustainable lunar exploration - PMC - PubMed Central, accessed January 14, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12357894/

6. Supporting the Mind in Space: Psychological Tools for Long-Duration Missions, accessed January 14, 2026, https://www.i-jmr.org/2024/1/e66626/

7. Moon 2 Mars Space Radiation Protection “Buying Down” Risks to Crew, accessed January 14, 2026, https://ntrs.nasa.gov/api/citations/20250006168/downloads/ASCEND%20Simonsen%20draft%201.pdf

8. Bioastronautics: Definition and Scope: Why Risk Humans for Space Exploration, accessed January 14, 2026, https://www.researchgate.net/publication/375491497_Bioastronautics_Definition_and_Scope_Why_Risk_Humans_for_Space_Exploration

9. Vast Announces the Haven-1 and Vast-1 Missions. — an update by VAST - Vast Space, accessed January 14, 2026, https://www.vastspace.com/updates/vast-announces-the-haven-1-and-vast-1-human-spaceflight-mission-launched-by-spacex-on-a-dragon-spacecraft

10. Spaceflight-associated neuro-ocular syndrome: potential etiologies and connections to the glymphatic system | Journal of Neurophysiology | American Physiological Society, accessed January 14, 2026, https://journals.physiology.org/doi/full/10.1152/jn.00056.2024

11. Spaceflight Associated Neuro-ocular Syndrome (SANS) and its countermeasures - PubMed, accessed January 14, 2026, https://pubmed.ncbi.nlm.nih.gov/39971096/

12. (PDF) Spaceflight Associated Neuro-ocular Syndrome (SANS) and ..., accessed January 14, 2026, https://www.researchgate.net/publication/389061737_Spaceflight_Associated_Neuro-ocular_Syndrome_SANS_and_Its_Countermeasures

13. Glymphatic system: an emerging therapeutic approach for neurological disorders - Frontiers, accessed January 14, 2026, https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2023.1138769/full

14. A perspective on the evidence for glymphatic obstruction in spaceflight associated neuro-ocular syndrome and fatigue - PMC - PubMed Central, accessed January 14, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10901896/

15. Sleep and optic disc edema in spaceflight associated neuro-ocular syndrome (SANS) - PMC, accessed January 14, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11427688/

16. Musculoskeletal responses to spaceflight: mechanisms ..., accessed January 14, 2026, https://journals.physiology.org/doi/10.1152/ajpcell.00649.2025

17. Self-Generated Lower Body Negative Pressure Exercise, a Low Power Countermeasure for Deep-Space Missions S. R. Velichala1, R. D., accessed January 14, 2026, https://www.hou.usra.edu/meetings/lunarsurface24/pdf/5003.pdf

18. The Mobile Lower Body Negative Pressure Gravity Suit for Long-Duration Spaceflight - Frontiers, accessed January 14, 2026, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2020.00977/full

19. Part 1: The Space Radiation Environment - NASA Technical Reports Server, accessed January 14, 2026, https://ntrs.nasa.gov/api/citations/20250004252/downloads/Book%20Chapter.pdf

20. Mechanisms and Countermeasures for Muscle Atrophy in Microgravity - PubMed, accessed January 14, 2026, https://pubmed.ncbi.nlm.nih.gov/39768210/

21. Musculoskeletal Responses to Spaceflight: Mechanisms, Countermeasures, and Key Gaps, accessed January 14, 2026, https://journals.physiology.org/doi/prev/20251111-aop/pdf/10.1152/ajpcell.00649.2025

22. Risk of Spaceflight-induced Changes to Bone, leading to In-mission - NASA, accessed January 14, 2026, https://www.nasa.gov/wp-content/uploads/2025/11/hsrb-bone-risk-record-rev-c-web.pdf?emrc=bce10e

23. Counteracting Bone and Muscle Loss in Microgravity - NASA, accessed January 14, 2026, https://www.nasa.gov/missions/station/iss-research/counteracting-bone-and-muscle-loss-in-microgravity/

24. Innovative Radiation Shielding Technologies | ACT of ESA - European Space Agency, accessed January 14, 2026, https://www.esa.int/gsp/ACT/projects/Radiation/

25. ESA - The radiation showstopper for Mars exploration - European Space Agency, accessed January 14, 2026, https://www.esa.int/Science_Exploration/Human_and_Robotic_Exploration/The_radiation_showstopper_for_Mars_exploration

26. Space radiation shielding - CSIRO, accessed January 14, 2026, https://www.csiro.au/en/research/technology-space/astronomy-space/space-technologies/radiation-shielding

27. Radiation Shielding in Space - StemRad, accessed January 14, 2026, https://stemrad.com/blocking-space-radiation-in-deep-space/

28. Radioprotection redefined: drug discovery at the intersection of tardigrade biology and translational pharmacology - Frontiers, accessed January 14, 2026, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1713914/full

29. Microbiota-Induced Radioprotection: A Novel Approach to Enhance Human Radioresistance with In-Situ Genetically Engineered Gut Bacteria - MDPI, accessed January 14, 2026, https://www.mdpi.com/2673-8007/5/1/1

30. NASA Achieves Water Recovery Milestone on International Space Station, accessed January 14, 2026, https://www.nasa.gov/missions/station/iss-research/nasa-achieves-water-recovery-milestone-on-international-space-station/

31. accessed January 14, 2026, https://news.fiu.edu/2025/water-recycling-is-paramount-for-space-stations-and-long-duration-missions-an-environmental-engineer-explains-how-the-iss-does-it#:~:text=To%20make%20human%20missions%20to,goal%20is%20now%20in%20reach.

32. Next Generation Water Recovery for a Sustainable Closed Loop Living - ResearchGate, accessed January 14, 2026, https://www.researchgate.net/publication/363956225_Next_Generation_Water_Recovery_for_a_Sustainable_Closed_Loop_Living

33. Water Processing for Space Exploration, accessed January 14, 2026, https://ntrs.nasa.gov/api/citations/20250002530/downloads/Water%20Processing%20for%20Space%20Exploration.pdf

34. European Scientists Turn Air into Food for Moon and Mars Missions | Firstpost America | N18G - YouTube, accessed January 14, 2026, https://www.youtube.com/watch?v=UKbzRZ8OR74

35. Synthetic Biology to Support Human Exploration of Deep Space - NASA Technical Reports Server (NTRS), accessed January 14, 2026, https://ntrs.nasa.gov/citations/20240001989

36. A greener future for Earth through space exploration research - The University of Melbourne, accessed January 14, 2026, https://www.unimelb.edu.au/newsroom/news/2025/november/a-greener-future-for-earth-through-space-exploration-research

37. LEAF – Lunar Effects on Agricultural Flora, An Artemis III Deployed Instrument, accessed January 14, 2026, https://ttu-ir.tdl.org/server/api/core/bitstreams/0583caf9-c657-4c9b-baf7-c6f7287a721d/content

38. NASA locked them away for a year to test Mars simulation survival—what they did with a PS4 will stun you | - The Times of India, accessed January 14, 2026, https://timesofindia.indiatimes.com/science/nasa-locked-them-away-for-a-year-to-test-mars-simulation-survivalwhat-they-did-with-a-ps4-will-stun-you/articleshow/123365899.cms

39. Mind over Mars: The psychology of space exploration, with Suzanne Bell, PhD, accessed January 14, 2026, https://www.apa.org/news/podcasts/speaking-of-psychology/mars-habitat

40. Analyzing the Psychological Impact of the First Mars Habitat Simulation - KBR, accessed January 14, 2026, https://www.kbr.com/en/insights-news/stories/analyzing-psychological-impact-first-mars-habitat-simulation

41. Space psychology: a comprehensive approach to the future of astronaut wellbeing, accessed January 14, 2026, https://www.frontiersin.org/journals/virtual-reality/articles/10.3389/frvir.2024.1446796/full

42. Haven-1 - Supercluster, accessed January 14, 2026, https://www.supercluster.com/launches/haven-1

43. Haven-1 - Vast Space, accessed January 14, 2026, https://www.vastspace.com/haven-1

44. Systematic review of the effectiveness of standalone passive countermeasures on microgravity-induced physiologic deconditioning - PubMed Central, accessed January 14, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11045828/

45. NASA Selects First Lunar Instruments for Artemis Astronaut Deployment, accessed January 14, 2026, https://www.nasa.gov/news-release/nasa-selects-first-lunar-instruments-for-artemis-astronaut-deployment/

46. Advanced biosensors for monitoring astronauts' health during long-duration space missions | Request PDF - ResearchGate, accessed January 14, 2026, https://www.researchgate.net/publication/324134431_Advanced_biosensors_for_monitoring_astronauts'_health_during_long-duration_space_missions

47. Bio-Sensorized Space System for Astronaut's Upper Body Temperature Monitoring During - Semantic Scholar, accessed January 14, 2026, https://pdfs.semanticscholar.org/02c1/77077108bca67d0d0526c7a9488ac478b6e8.pdf

48. Space medicine team reaches for the stars to cure diseases - UTHealth Houston, accessed January 14, 2026, https://www.uth.edu/news/story/space-medicine-team-reaches-for-the-stars-to-cure-diseases